NT-proBNP Fast Test Kit - India CDSCO Medical Device Registration

NT-proBNP Fast Test Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000153_580cb484c1bde95053451e8e8c06b28c_a20a4c19a556489aa41db51ef9e86fb5. This device is marketed under the brand name Immunofluorescence Assay. The license holder is Cipla Limited, and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class C

NT-proBNP Fast Test Kit

UID: IMP/IVD/2022/000153_580cb484c1bde95053451e8e8c06b28c_a20a4c19a556489aa41db51ef9e86fb5

Brand Name

Immunofluorescence Assay

License Holder

Cipla Limited

Device Class

Class C

Approving Authority

CDSCO

Product Information

NT-proBNP Fast Test Kit (Immunofluorescence Assay) is intended for in vitro quantitative determination of N-terminal B-type natriuretic peptide precursor (Immunofluorescence Assay) in human serum, plasma or whole blood samples. This test is used as an aid in the clinical diagnosis, prognosis and evaluation of Heart Failure (Immunofluorescence Assay)